US 10052363
Mesenchymal stem cells for the treatment of CNS diseases
granted A61KA61K35/12A61K35/28
Quick answer
US patent 10052363 (Mesenchymal stem cells for the treatment of CNS diseases) held by BRAINSTORM CELL THERAPEUTICS LTD. expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BRAINSTORM CELL THERAPEUTICS LTD.
- Grant date
- Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K35/12, A61K35/28, A61K38/185, A61P